| No. | Author | Title | Publication | Volume | Number | Pages | Year | Publishers |
|---|---|---|---|---|---|---|---|---|
| 1 | Heterocyclic Moieties as HDAC Inhibitors: Role in cancer therapeutics | Mini Reviews in Medicinal Chemistry | 22 | 12 | 1648-1706 | 2022 | Bentham Science Publishers direct | |
| 2 | Synthesis and HDAC1 inhibitory activity of a novel series of coumarin-based amide derivatives for treatment of cancer | Future Medicinal Chemistry | 15 | 18 | 1669-1685 | 2023 | Taylor & Francis | |
| 3 | Synthesis, biological evaluation and docking studies of methylene bearing cyanopyrimidine derivatives possessing a hydrazone moiety as potent Lysine specific demethylase-1 (LSD1) inhibitors: A promising anticancer agents | Bioorganic Chemistry | 126 | 105885 | 2022 | Elsevier | ||
| 4 | Piperazine scaffold: A remarkable tool in generation of diverse pharmacological agents | European journal of medicinal chemistry | 102 | 487-529 | 2015 | Elsevier | ||
| 5 | Exploring cyclopropylamine containing cyanopyrimidines as LSD1 inhibitors: Design, synthesis, ADMET, MD analysis and anticancer activity profiling | Bioorganic Chemistry | 147 | 107336 | 2024 | Elsevier | ||
| 6 | Green recipes to quinoline: A review | European Journal of Medicinal Chemistry | 164 | 121-170 | 2019 | Elsevier | ||
| 7 | EGFR INHIBITORS: ROLE IN CANCER THERAPY | |||||||
| 8 | Synthesis, and reverse screening of 6â(3, 4, 5âtrimethoxyphenyl) pyrimidineâ5âcarbonitrile derivatives as anticancer agents: PartâII | Journal of Heterocyclic Chemistry | 59 | 4 | 771-788 | 2022 | Wiley Online Library | |
| 9 | Synthesis, in-Silico studies and biological evaluation of pyrimidine based thiazolidinedione derivatives as potential anti-diabetic agent | Bioorganic Chemistry | 134 | 106449 | 2023 | Elsevier |
